LY Group
The computed 12-month bankruptcy probability of LY Group is 0.3% (very low). The 2024 annual accounts show equity of €269k and a net result of €145k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 14% of 6565 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €269k |
| Net result | €145k |
| Staff (FTE) | 8.2 |
| Better than sector | 14% |
Strong profile, led by profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 14.6% | 66.7% | |
| Net result | €145k | €46k | |
| Equity | €269k | €79k | |
| Gross operating margin | €601k | €78k | |
| Staff costs | €187k | €21k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €383k |
| Net profit | €145k |
| Cash flow | €296k |
| Staff costs | €187k |
| Income taxes | €57k |
| Dividends | - |
| Total assets | €1.85M |
| Equity | €269k |
| Debt | €1.58M |
| of which ≤ 1y | €396k |
| of which > 1y | €1.18M |
| Working capital | €133k |
| Employees (FTE) | 8.2 |
| 2024 | |
|---|---|
| Current ratio | 1.34 |
| Quick ratio | 1.34 |
| Working capital ratio | 7.2% |
| Solvency | 14.6% |
| Debt / equity | 5.87 |
| Long-term debt ratio | 4.40 |
| Interest coverage | 12.76 |
| Gross margin | - |
| Net margin | - |
| ROA | 7.8% |
| ROE | 53.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.85M |
| Fixed assets | 21/28 | €1.32M |
| Intangible fixed assets | 21 | €1k |
| Tangible fixed assets | 22/27 | €1.32M |
| Financial fixed assets | 28 | €100 |
| Current assets | 29/58 | €528k |
| Amounts receivable within one year | 40/41 | €53k |
| Cash & bank | 54/58 | €359k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.85M |
| Equity | 10/15 | €269k |
| Contributions / capital | 10/11 | €50k |
| Reserves | 13 | €74k |
| Accumulated profits (losses) | 14 | €145k |
| Amounts payable | 17/49 | €1.58M |
| Amounts payable after one year | 17 | €1.18M |
| Amounts payable within one year | 42/48 | €396k |
| Trade debts payable within one year | 44 | €155k |
| Income statement | ||
| Gross operating margin | 9900 | €601k |
| Operating result | 9901 | €232k |
| Financial income | 75 | €312 |
| Financial charges | 65 | €30k |
| Result before taxes | 9903 | €202k |
| Income taxes | 67/77 | €57k |
| Net result for the period | 9904 | €145k |
| Result to be appropriated | 9905 | €145k |
| NACE primary | Human health(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 18-03-2021 |
| Status | Active |
| Postal code | 1040 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21363B0404/00G012 | Brussels | 407 m² | 1 · 375 m² | 19.1 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
30-10-2024 Articles of association amended, translation of the articles, coordination of the articles and amendment of specific articles
Technical details
{
"notary": {
"name": "Alexis Heindryckx",
"firm_city": null,
"firm_name": null,
"office_city": "Anderlecht",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-10-30",
"filing_date": "2024-10-28",
"act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), OBJET"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-10-16",
"unanimous": true
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment",
"object_change"
],
"scope": "translation_only",
"trigger": "other",
"language_after": "nl",
"language_before": "fr"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0765.360.682",
"name_full_after": "LY Group",
"legal_form_after": "SRL",
"name_full_before": "LY Group",
"current_zetel_raw": "Avenue G\u00E9n\u00E9ral Bernheim 18-20 1040 Etterbeek",
"legal_form_before": "SRL"
},
"special_mandates": [],
"articles_modified": [
{
"summary": "De object van de vennootschap is uitgebreid met activiteiten gerelateerd aan de tandartspraktijk, het oprichten van medische centra, het bevorderen van tandheelkundig onderzoek, het verstrekken van management- en adviesdiensten, de commercialisering van software en games, en het kopen, verkopen en e",
"new_text": "La soci\u00E9t\u00E9 a pour objet principal tant en Belgique qu\u2019\u00E0 l\u2019\u00E9tranger, pour compte propre ou compte de tiers ou en participation avec ceux-ci, toutes op\u00E9rations civiles, commerciales, financi\u00E8res, mobili\u00E8res et immobili\u00E8res portant directement ou indirectement \u00E0 exercer :\n1. Toutes op\u00E9rations li\u00E9es directement ou indirectement \u00E0 l\u2019exercice de la profession de dentiste, \u00E0 l\u2019exclusion des fonctions att",
"change_kind": "amended",
"article_title": null,
"article_number": "3"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"co_filed_documents": [
"les statuts coordonn\u00E9s",
"une exp\u00E9dition de l\u2019acte"
],
"shareholder_rights": null,
"voorwerp_change_summary": "De object van de vennootschap is uitgebreid door het toevoegen van activiteiten gerelateerd aan de tandartspraktijk, het oprichten van medische centra en laboratoria, het bevorderen van tandheelkundig onderzoek en ontwikkeling, het verstrekken van management- en adviesdiensten, de commercialisering van software en games, en het kopen, verkopen en exploiteren van onroerend goed.",
"capital_structure_change": null,
"coordinated_text_lineage": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | LY Group |